| Report ID | 281385 |
| Drug Identification Number | 02230894 |
| Brand name | TOPAMAX 100MG |
| Common or Proper name | Topamax 100mg |
| Company Name | JANSSEN INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TOPIRAMATE |
| Strength(s) | 100MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 60ct |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2026-07-24 |
| Actual discontinuation date | |
| Remaining supply date | |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Enough supply to support orders until discontinuation date |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 19 GREEN BELT DRIVE TORONTO, ONTARIO CANADA M3C 1L9 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-03-25 | French | Compare |
| v1 | 2026-03-25 | English | Compare |
Showing 1 to 2 of 2